151
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Targeted metabolomics as a tool for the diagnosis of kidney disease in Type II diabetes mellitus

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 184-190 | Received 09 Oct 2020, Accepted 19 Feb 2021, Published online: 10 May 2021
 

ABSTRACT

Background: Diabetic kidney disease (DKD) is an increasing health problem and an extra burden to health services. The study of characteristic metabolic alterations of DKD is crucial for a better understanding of pathogenesis to identify new potential biomarkers and drug targets. We hypothesized that metabolic profiling of amino acids, acylcarnitines, and organic acids are useful new biomarkers for the diagnosis of the early stages of DKD

Methods: The hypothesis was testing in a case-control study of 232 patients with type 2 diabetes mellitus and 150 healthy controls. Patients were classified according to urinary albumin and estimated glomerular filtration rate (eGFR) into 100 with normoalbuminuria and 132 with microalbuminuria group. Eighteen AcylCNs and 17 amino acids were measured in the blood by tandem mass spectrometry while 17 urinary organic acids were quantitatively measured by gas chromatography – mass spectrometry.

Results: Regression analysis found that dodecanoylcarnitines C12 (effect size 2.03 [95%CI 1.73–2.32]), triglylcarnitine C5:1 (2.01 [1.70–2.30]), and isovalerylcarnitine C5 (1.78 [1.48–2.07]) were stronger predictors of albumin/creatinine ratio than HbA1c (1.50 [1.20–1.78]) and hence they could serve as potential biomarkers for the diagnosis of the early stages of DKD.

Conclusions: Targeted metabolic profiling offers a new, non-invasive approach for detecting biomarkers for the early diagnosis of DKD suggesting new pathogenetic phases that might be new targets for treatment.

Acknowledgements

The authors would like to express their sincere appreciation to all the staff members of the clinical biochemistry and molecular diagnostics department, National Liver Institute and the participant patients for their contribution to this work.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research was performed using the instruments supplied by a grant from the Science and Technology Development Fund (STDF) [N2338].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.